|
Feb 20
|
Lilly’s former M&A chief scours the landscape for potential deals as Immunocore’s new CFO
|
|
Feb 19
|
Immunocore to report fourth quarter and full year 2024 financial results and host call on February 26, 2025
|
|
Feb 17
|
Immunocore Gears Up to Report Q4 Earnings: Is a Beat in Store?
|
|
Jan 2
|
Immunocore appoints Travis Coy, previously a Non-Executive Director, as its EVP, Chief Financial Officer and Head of Corporate Development
|
|
Sep 29
|
Immunocore Holdings plc (IMCR): Worst 52-Week Low Stock to Buy Now
|
|
Sep 27
|
Immunocore Holdings plc (NASDAQ:IMCR) Ranks Low On The List Of Worst Falling Stocks To Buy
|
|
Sep 25
|
Immunocore Holdings plc (IMCR) Hits 52-Week Low Despite 34% Surge in KIMMTRAK Sales
|
|
Aug 30
|
Immunocore Holdings plc (IMCR): Top ADR Stock According to Hedge Funds
|
|
Aug 29
|
Immunocore announces transition of Chief Financial Officer
|
|
Aug 1
|
Immunocore to report second quarter 2024 financial results and host call on August 8, 2024
|
|
Jul 31
|
Is There An Opportunity With Immunocore Holdings plc's (NASDAQ:IMCR) 32% Undervaluation?
|
|
Jun 18
|
Immunocore announces randomization of first patient in the global, registrational Phase 3 clinical trial testing brenetafusp for the treatment of first-line advanced or metastatic cutaneous melanoma
|
|
May 24
|
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
|
|
May 11
|
Analysts Have Made A Financial Statement On Immunocore Holdings plc's (NASDAQ:IMCR) First-Quarter Report
|
|
May 8
|
Immunocore Holdings PLC Reports Q1 2024 Earnings: Misses EPS Estimates, Surpasses Revenue Forecasts
|
|
May 8
|
Immunocore reports first quarter financial results and provides a business update
|
|
Apr 24
|
Immunocore announces upcoming presentation and posters at ASCO 2024
|
|
Apr 4
|
Immunocore to present at upcoming investor conferences
|
|
Mar 13
|
Billionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfolio
|
|
Mar 5
|
Immunocore presented two posters at CROI 2024
|